Loading the map…

Research and experimental development on biotechnology · Cambridge

Revolo Biotherapeutics

Revolo Biotherapeutics Limited

Net liabilitiesLosses 2 years runningActiveLatest figures: 2026Abridged accountsCompany only14 years on the register

Private limited company registered in Cambridge, classed under “Research and experimental development on biotechnology”.

Headline figures

FY to Mar 2026 · Company only

Turnover

For subscribers

Profit after tax

−£5.84m

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20252026
Profit after tax−£5.84m
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for all 2 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Timeline

Checked 2026-10-31

  1. Accounts
    Total exemption full accounts made up to 31 March 2026
  2. Shares
    Statement of capital following an allotment of shares on 18 June 2026 · GBP 629.9757 (and 29 more like it since 19 October 2017)
  3. Directors
    Appointment of Mr Marek Stefan Gumienny as a director on 12 December 2025
  4. Accounts
    Total exemption full accounts made up to 31 March 2025
  5. Directors
    Appointment of Mr Gunnar Jan Walstam as a director on 15 July 2025
  6. Address
    Registered office address changed from C/O Bcs Windsor House, Station Court Station Road Great Shelford Cambridgeshire CB22 5NE England to C/O Windsor House Station Court, Stati…
  7. Directors
    Termination of appointment of David Peabody Southwell as a director on 19 May 2025
  8. Charges
    Registration of charge 078284140002, created on 4 March 2025
  9. Accounts
    Total exemption full accounts made up to 31 March 2024
  10. Directors
    Appointment of David Peabody Southwell as a director on 15 December 2023
  11. Directors
    Termination of appointment of Jonathan Michael Norman Rigby as a director on 3 January 2024
  12. Directors
    Appointment of Jones Woodrow Bryan as a director on 3 January 2024
  13. 27 earlier
    1. Accounts
      Total exemption full accounts made up to 31 March 2023
    2. Directors
      Director's details changed for Ms Marla Susan Persky on 9 February 2023
    3. Directors
      Director's details changed for Dr Babatunde Otulana on 9 February 2023
    4. Directors
      Director's details changed for Mr Glen Thomas Giovannetti on 9 February 2023
    5. Accounts
      Group of companies' accounts made up to 31 March 2022
    6. Filing
      Resolutions (and 3 more like it since 7 March 2018)
    7. Filing
      Memorandum and Articles of Association (and 1 more like it since 28 September 2020)
    8. Accounts
      Group of companies' accounts made up to 31 March 2021
    9. Directors
      Appointment of Dr Babatunde Otulana as a director on 1 August 2021
    10. Directors
      Director's details changed for Ms Maria Susan Persky on 1 July 2021
    11. Directors
      Appointment of Ms Maria Susan Persky as a director on 1 July 2021
    12. Directors
      Appointment of Mr Glen Thomas Giovannetti as a director on 1 July 2021
    13. Directors
      Appointment of Mr Michael Albisser as a director on 25 January 2021
    14. Name
      Certificate of change of name
    15. Directors
      Termination of appointment of Dominik Escher as a director on 27 November 2020
    16. Directors
      Appointment of Mr Peter Scott Greenleaf as a director on 23 November 2020
    17. Shares
      Second filing of a statement of capital following an allotment of shares on 23 September 2020 · GBP 343.3378 (and 2 more like it since 13 November 2018)
    18. Directors
      Termination of appointment of Clive Page as a director on 23 October 2020
    19. Accounts
      Group of companies' accounts made up to 31 March 2020
    20. Directors
      Appointment of Mr Isaac Cheng as a director on 17 September 2020
    21. Directors
      Termination of appointment of Michael Albisser as a director on 17 September 2020
    22. Directors
      Termination of appointment of Gunnar Walstam as a director on 17 September 2020
    23. Directors
      Termination of appointment of Christopher Smith as a director on 17 September 2020
    24. Directors
      Termination of appointment of Richard Nagle as a director on 3 July 2020
    25. Directors
      Appointment of Mr Jonathan Michael Norman Rigby as a director on 1 April 2020
    26. Directors
      Termination of appointment of Ben Major George Cons as a director on 14 February 2020
    27. Directors
      Termination of appointment of David Colin Beadle as a director on 24 October 2019

From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.

Questions people ask

›What does Revolo Biotherapeutics do?

Private limited company registered in Cambridge, classed under “Research and experimental development on biotechnology”.

›How much turnover does Revolo Biotherapeutics make?

Answered in the full report

›Is Revolo Biotherapeutics profitable?

No: it made a loss after tax of £5.84m in the year to 31 March 2026, its latest filed accounts.

›How many people work at Revolo Biotherapeutics?

Answered in the full report

›Who runs and owns Revolo Biotherapeutics?

Its directors are Bcs Cosec Limited, Michael Albisser, Jones Woodrow Bryan, Isaac S. Cheng, Glen Thomas Giovannetti and 5 more. Its owners are shown to subscribers.

›Where is Revolo Biotherapeutics based?

Its registered office is C/O Windsor House Station Court, Station Road, Great Shelford, Cambridge, CB22 5NE, in Cambridge.

›When was Revolo Biotherapeutics founded?

Revolo Biotherapeutics Limited was incorporated on 31 October 2011.

›Is Revolo Biotherapeutics still trading?

The register lists Revolo Biotherapeutics Limited as active.

More companies in Cambridge →